JP2025516583A5 - - Google Patents

Info

Publication number
JP2025516583A5
JP2025516583A5 JP2024566316A JP2024566316A JP2025516583A5 JP 2025516583 A5 JP2025516583 A5 JP 2025516583A5 JP 2024566316 A JP2024566316 A JP 2024566316A JP 2024566316 A JP2024566316 A JP 2024566316A JP 2025516583 A5 JP2025516583 A5 JP 2025516583A5
Authority
JP
Japan
Prior art keywords
capsid protein
modified
targeting peptide
pharmaceutical composition
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024566316A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025516583A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/021905 external-priority patent/WO2023220287A1/en
Publication of JP2025516583A publication Critical patent/JP2025516583A/ja
Publication of JP2025516583A5 publication Critical patent/JP2025516583A5/ja
Pending legal-status Critical Current

Links

JP2024566316A 2022-05-11 2023-05-11 脳深部構造を標的とするアデノ随伴ウイルスベクター Pending JP2025516583A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263340823P 2022-05-11 2022-05-11
US63/340,823 2022-05-11
US202263342324P 2022-05-16 2022-05-16
US63/342,324 2022-05-16
PCT/US2023/021905 WO2023220287A1 (en) 2022-05-11 2023-05-11 Adeno-associated viral vectors for targeting deep brain structures

Publications (2)

Publication Number Publication Date
JP2025516583A JP2025516583A (ja) 2025-05-30
JP2025516583A5 true JP2025516583A5 (enExample) 2026-05-18

Family

ID=88730946

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024566316A Pending JP2025516583A (ja) 2022-05-11 2023-05-11 脳深部構造を標的とするアデノ随伴ウイルスベクター

Country Status (11)

Country Link
US (1) US20260183425A1 (enExample)
EP (1) EP4522272A4 (enExample)
JP (1) JP2025516583A (enExample)
KR (1) KR20250031153A (enExample)
CN (1) CN119654334A (enExample)
AU (1) AU2023269646A1 (enExample)
CA (1) CA3252951A1 (enExample)
CO (1) CO2024016255A2 (enExample)
IL (1) IL316908A (enExample)
MX (1) MX2024013890A (enExample)
WO (1) WO2023220287A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4570260A1 (en) * 2023-12-14 2025-06-18 Medizinische Hochschule Hannover Viral vector for transduction of adipocytes
WO2025231406A1 (en) * 2024-05-02 2025-11-06 The Children's Hospital Of Philadelphia Methods to increase transduction of ependyma cells in brain
WO2025231387A1 (en) * 2024-05-02 2025-11-06 The Children's Hospital Of Philadelphia Globus pallidus route of administration for deep brain gene therapies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6342886B2 (ja) * 2012-04-18 2018-06-13 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia Aavカプシドバリアントを使用した高効率な遺伝子導入のための組成物及び方法
SI3645551T1 (sl) * 2017-06-27 2024-06-28 Regeneron Pharmaceuticals, Inc. S tropizmi spremenjeni rekombinantni virusni vektorji in njihova uporaba za tarčni vnos genetskega materiala v človeške celice
US20220096574A1 (en) * 2019-01-29 2022-03-31 Holobiome, Inc. Methods and compositions for treating and preventing central nervous system disorders and other conditions caused by gut microbial dysbiosis
TW202111127A (zh) * 2019-07-24 2021-03-16 美商航海家醫療公司 用於治療亨丁頓舞蹈症之組合物及方法
WO2021025995A1 (en) * 2019-08-02 2021-02-11 Voyager Therapeutics, Inc. Aav variants with enhanced tropism
CN115023242B (zh) * 2019-11-22 2025-03-14 费城儿童医院 腺相关病毒载体变体

Similar Documents

Publication Publication Date Title
JP2021520203A (ja) 減少した肝臓向性を有するAAV9とAAVrh74とのハイブリッド組換えアデノ随伴ウイルス血清型
JP2023514242A5 (enExample)
JP2021534809A (ja) Aavカプシドの向性の再指向化
RU2017121593A (ru) Векторы aav, нацеленные на центральную нервную систему
JP7663492B2 (ja) 細胞透過性ペプチド
US20260091120A1 (en) Cell-penetrating peptides
JP2022520232A5 (enExample)
JP2024517710A5 (enExample)
US9809823B2 (en) DNA aptamers for promoting remyelination
WO2003045439A1 (en) Genetic remedies for neurodegenerative diseases
JP2024515459A5 (enExample)
AU2024276934A1 (en) Adeno-associated virus capsid protein, adeno-associated virus containing same, vector and use thereof
JP2025513066A5 (enExample)
JP2025534332A (ja) 治療用核酸及びその使用方法
CN116368157A (zh) 用于溶解蛋白质聚集体的组合物和方法
TW202523846A (zh) 用於治療與共濟蛋白(frataxin)不足有關之疾病之組合物及方法
Peng et al. Viral-mediated gene therapy in pediatric neurological disorders
JP2024527742A5 (enExample)
US20230330267A1 (en) Novel engineered capsid serotype of recombinant adeno-associated viral vector with enhanced transduction efficiency and widespread distribution in the brain
JP2025510975A5 (enExample)
AU2025248711A1 (en) Gene Therapy For Addiction Disorders
JP2024501022A5 (enExample)
CN113117096B (zh) 一种NCAM模拟肽修饰的pH敏感基因仿生递释系统及其应用
WO2022055320A1 (ko) 표적화된 유전자 전달을 위한 아데노-부속 바이러스 벡터
JP2022552003A5 (enExample)